Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
6782.TW
Strong BuyFull HouseAPPROVEVisco Vision Inc. · Healthcare · Taiwan · $481M · Avg Vol: $4M/d
Visco Vision operates in a high-barrier, precision-manufacturing niche with demonstrable pricing power. A significant 10.4% forward-EPS consensus revision indicates strong earnings momentum. The company benefits from secular growth in the high-end healthcare/contact lens sector, which exhibits defensive qualities against current macro volatility, effectively compounding value while the market focuses on cyclical noise.
COMPANY DESCRIPTION
Visco Vision Inc. manufactures silicone hydrogel contact lenses and related eye care products. The company stands out as one of the few global manufacturers with proprietary silicone hydrogel material formulations and automated production lines. It is a leading ODM/OEM contact lens manufacturer in Asia, focused on high-oxygen-permeability eye care solutions.
FINANCIAL SUMMARY (TWD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 2.8B | 2.4B | 3.7B | 4.2B | 15.0% | 4.7B | 5.2B | 6.0B | 19.4% |
| EPS (TWD) | 8.11 | 11.11 | 4.79 | 10.10 | 14.08 | 14.8% | 16.50 | 18.04 | 21.54 | 23.7% |
| Shares | — | 54.7M | 63.0M | 63.0M | 63.0M | +15.1% | 63.0M | — | — | — |
| Debt | — | 1.4B | 1.1B | 844.3M | 481.9M | -30.2% | 656.8M | — | — | — |
| Equity | — | 3.1B | 3.0B | 3.7B | 4.4B | 12.8% | — | — | — | — |
| Op CF | — | 985.1M | 353.1M | 1.1B | 1.4B | 11.1% | 1.3B | — | — | — |
| Inv CF | — | -963.0M | -938.8M | -512.4M | -732.1M | — | — | — | — | — |
| Fin CF | — | 1.4B | -666.8M | -418.1M | -699.0M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 6782.TW are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 6782.TW | Visco Vision Inc.(you) | $481M | 99 | Strong Buy |
| 4771.TW | Vizionfocus Inc. | $383M | 90 | Strong Buy |
| 4107.TWO | Bioteque Corporation | $250M | 97 | Strong Buy |
| 6491.TW | Pegavision Corporation | $916M | 94 | Strong Buy |
| 4126.TWO | Pacific Hospital Supply Co., Ltd | $178M | 94 | Strong Buy |
| 1783.TW | Maxigen Biotech Inc. | $115M | 87 | Strong Buy |
| 1752.TW | Nang Kuang Pharmaceutical Co., Ltd. | $102M | 84 | Strong Buy |
| 4116.TWO | BenQ Medical Technology Corporation | $56M | 95 | Strong Buy |
| 1565.TWO | St.Shine Optical Co.,Ltd. | $156M | 69 | Buy |
| 6527.TWO | Crystalvue Medical Corporation | $60M | 81 | Strong Buy |
Peer medians: ROE 4.1% · P/E 15.8x · Gross margin 41.6%